Trending News

New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis

New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis

What did the research discover? Researchers created a detailed map of the cells in the synovial tissue of people with rheumatoid arthritis (RA) by studying over 314,000 cells from 79 donors. They found six different types of cell patterns, called cell-type abundance phenotypes (CTAPs), which show various immune cell compositions in the inflamed joint tissue. These...

New Hope for Stomach Cancer: Combining Immunotherapy and Chemotherapy Before Surgery

New Hope for Stomach Cancer: Combining Immunotherapy and Chemotherapy Before Surgery

What Did the Research Discover? Gastric and gastroesophageal junction (G/GEJ) cancers are among the deadliest cancers, and while immunotherapy has become a standard treatment for advanced cases, its role in earlier-stage disease is not well understood. The PANDA trial investigated whether neoadjuvant (before surgery) immunotherapy combined with chemotherapy could...

FDA New Update: New Treatments, Safety Alerts, and Medical Advancements

FDA New Update: New Treatments, Safety Alerts, and Medical Advancements

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation...

Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses

Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses

What did the research discover? Researchers studied how activating a specific protein called Nrf2 could help the immune cells in the lungs, called alveolar macrophages, fight bacterial infections in chronic obstructive pulmonary disease (COPD). COPD makes it harder for these immune cells to remove harmful bacteria, leading to frequent lung infections and worsening...

Gene Therapy Offers New Hope for Retinitis Pigmentosa Patients

Gene Therapy Offers New Hope for Retinitis Pigmentosa Patients

What Did the Research Discover? Researchers studied retinitis pigmentosa (RP), an inherited eye disease that causes vision loss due to the death of light-sensitive cells in the retina. RP affects about 1 in 5,000 people worldwide, leading to symptoms like night blindness and tunnel vision. The condition is caused by genetic mutations, and more than 90 genes have...

Risk Factors for Chronic Low Back Pain: What You Should Know

Risk Factors for Chronic Low Back Pain: What You Should Know

What did the research discover? This study found that nearly one-third (32%) of patients with acute low back pain (LBP) transitioned to chronic LBP within six months. The risk of developing chronic pain was significantly associated with: Higher scores on the Subgroups for Targeted Treatment Back Tool (SBT), which predicts persistent functional limitations. Exposure...